NEW YORK (GenomeWeb) – Russian genomics firm ReadSense has signed a deal with Strand Life Sciences to co-develop next-generation sequencing-based tests for the diagnosis of inherited diseases including hereditary forms of epilepsy and primary immunodeficiency disorders, the companies announced today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more